Navigation Links
Fish Oil Supplements Don't Help Depressed Heart Patients
Date:10/20/2009

Those who took them with antidepressant fared same as those who didn't

TUESDAY, Oct. 20 (HealthDay News) -- In a surprise and not very welcome finding, researchers report that fish oil supplements do not ease depression in individuals who suffer from both depression and coronary heart disease.

Participants in the study, which is published in the Oct. 21 issue of the Journal of the American Medical Association, were also taking the antidepressant sertraline (Zoloft). Some studies have suggested that the omega-3 fatty acids found in fish might enhance the effects of Zoloft.

"Unfortunately, it's not where we wanted to be. We were kind of disappointed, to say the least," said study author Robert M. Carney, a professor of psychiatry at Washington University School of Medicine in St. Louis.

The findings leave physicians still facing the problem of how to boost depression recovery rates so as to also lower cardiovascular risk. The question is a pressing one, given that depression can double or even triple the risk of dying in heart patients, Carney said.

"We're not just treating depression, we're treating a risk factor," he said.

Fish oil, or omega-3 fatty acid, supplements have been touted as a potential panacea for a variety of ailments, notably heart disease, but they have been losing their luster as of late.

A study published earlier this year found that patients receiving optimal drug therapy after experiencing a heart attack do not gain any additional benefit from taking supplemental omega-3 fatty acids. There was no difference in rates of heart attack, stroke, sudden cardiac death or death from any cause, regardless of whether they were taking the supplements or not.

That finding contradicted previous studies, which suggested that taking omega-3 fatty acids improved long-term survival.

Studies involving omega-3 fatty acids and depression have shown similarly uneven results.

For this study, 122 patients with major depression and coronary heart disease took 50 milligrams of Zoloft a day, then were randomized to receive either 2 grams a day of omega-3 acid ethyl esters or a corn-oil placebo capsule.

There was no difference in depression scores before and after 10 weeks of treatment, the researchers found.

The study authors noted that tweaking any of the variables in the study -- amount of Zoloft, dose of fish oil, form of fish oil or duration of treatment -- might yield more positive results.

In general, the effects of antidepressants in people with both depression and heart problems are the same as in a normal "healthy" population, Carney said.

"The problem, from our point of view, is that that's just not good enough," he added. "It's definitely better than placebo, better than doing nothing. We're trying to find a treatment or combination of treatments that's going to significantly improve the depression outcome."

Had this study turned out more positively, the next step would have been to see if improvements in depression translate into improvements in heart outcomes.

As it is, scientists are back to the drawing board.

"We're still exploring other possibilities," Carney said.

That includes an increased dose of omega-3, lengthening the study and identifying a subset of patients for whom this protocol might be more effective than antidepressants alone.

But it's not time to stop taking fish oil capsules yet, one expert said.

"The American Heart Association still does have recommendations based on the data we do have," said Dr. John Erwin III, professor of internal medicine at Texas A&M Health Science Center College of Medicine, and senior staff cardiologist with Scott & White Hospital in Temple.

"We also use fish oil to reduce triglyceride levels and it's very effective in that use. I wouldn't encourage people who are taking fish oil caplets to stop it now because of this study. It just means we have a little bit more work to do on the depression side of things," he said.

Some of the study authors, including Carney, declared financial ties with different pharmaceutical companies including Pfizer Inc., which makes Zoloft. The study was funded by the U.S. National Heart, Lung, and Blood Institute. GlaxoSmithKline Inc. provided both omega-3 and placebo capsules, while Pfizer supplied the Zoloft.

More information

The U.S. National Library of Medicine has more on omega-3 fatty acids.



SOURCES: Robert M. Carney, Ph.D., professor, psychiatry, Washington University School of Medicine, St. Louis; John Erwin III, M.D., associate professor of internal medicine, Texas A&M Health Science Center College of Medicine, and senior staff cardiologist, Scott & White Hospital, Temple; Oct. 21, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Chews-4-Health Dietary Supplements to be Featured on 'Beauty Spaces'
2. Valensa to Market Neptune Krill Oil NKO(R) Formulations for Joint Health and Eye Health Dietary Supplements
3. Jerome Bettis Endorses Chews-4-Health Dietary Supplements
4. Swanson Health Products' Vitamin E and Acai Dietary Supplements Pass Quality Control Tests Conducted by ConsumerLab.com
5. Astronauts Test Use of Nutritional Supplements in Space
6. August 2009 Mayo Clinic Health Letter Highlights Herbal Supplements, Groin Rashes and Hand Arthritis
7. Women's Health Expert Dr. Susan Lark Featured on Searchvitaminsupplements.com
8. Dr. David Williams Featured on Searchvitaminsupplements.com
9. National Council on Skin Cancer Prevention Encourages Americans to Obtain Vitamin D Through Diet and Supplements
10. Board-Certified Cardiologist Dr. Stephen Sinatra Featured on Searchvitaminsupplements.com
11. Jillian Michaels, Americas Toughest Trainer, Announces New Line of Weight-Loss Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters of Science in ... leaders with decades of experience who remain current practitioners in the field. With ... there is a renewed demand for versatile, data-driven leadership.The American University’s MS in ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... on Crystallization in Process Chemistry by Applying Simple PAT Tools . , ... compounds to isolate and purify the desired product. Chemists now spend more ...
(Date:1/23/2017)... ... 23, 2017 , ... Old School Labs™, makers of the wildly popular all-natural ... Breon Ansley to its growing team of brand ambassadors. The Olympia top finisher and ... less than a year was able to turn professional, participating in the 2013 NPC ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Crossing the Bar”: a moving and eloquent ... life. “Crossing the Bar” is the creation of published author, Charlotte Hotte, a North ... who credits the inspiration of the book to her sister, Denise, wishes to acknowledge ...
(Date:1/23/2017)... ... 23, 2017 , ... Valentine’s Day is a time when many people celebrate romance and love ... may be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering ... free. Or, spend $200 and get $50 free. , “A lot of people just ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Research and Markets has announced the addition of the ... their offering. ... The interventional radiology products market is expected to reach USD 8.02 ... CAGR of 4.8%. This market is segmented based on type, procedure, ... of this market are rising incidence of chronic diseases, rising geriatric ...
(Date:1/23/2017)... , Jan. 23, 2017 LifeVac, the ... a blocked airway and prevented choking deaths, welcomes ... advocate to the LifeVac team as Official Spokesperson. ... join the LifeVac team," said Arthur Lih , ... to represent LifeVac and his mission to raise awareness ...
(Date:1/23/2017)... TORONTO , Jan. 23, 2017 ... both 510(k) clearance from the U.S. Food and ... from Health Canada enabling the North American commercial ... (MIGS™) system for spine surgery, the 7D Surgical ... employs cutting-edge 3D optical technologies and machine vision ...
Breaking Medicine Technology: